Skip to main content
Log in

Respiratory superinfections after the use of third-generation cephem antibiotics

Superinfektionen der Atemwege nach Anwendung von Cephem-Antibiotika der dritten Generation

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

This paper is a report on our studies on superinfections in respiratory tract infections treated during the years 1981–1984. The isolated strains ofStaphylococcus aureus, Staphylococcus epidermidis, Streptococcus faecalis, Streptococcus faecium and glucose non-fermentative gram-negative rods such asPseudomonas aeruginosa were resistant to third-generation cephem antibiotics. These organisms proved to be widely distributed in hospitals and were frequently isolated from the sputum, excised lung and cardiac blood. The colonization of the sputum by bacteria in respiratory tract infections before, during and after treatment with third-generation cephem antibiotics revealed a tendency for these organisms to appear after treatment. Among the gram-positive cocci,S. faecium was most resistant to these antibiotics, followed byS. faecalis, S. epidermidis andS. aureus in that order. The incidence of resistant isolates in 1984 exceeded that in 1983, suggesting an annual increase in resistant bacteria.

Zusammenfassung

Wir berichten über unsere Studien zu Superinfektionen bei Infektionen der Atemwege, die von 1981–1984 behandelt wurden. Die isolierten Stämme vonStaphylococcus aureus, Staphylococcus epidermidis, Streptococcus faecalis undStreptococcus faecium sowie von Glukose nicht fermentierenden gramnegativen Stäbchen wiePseudomonas aeruginosa waren resistent gegen Cephem-Antibiotika der dritten Generation. Es zeigte sich, daß diese Erreger in den Krankenhäusern weit verbreitet waren; sie wurden häufig aus Sputum, Lungenexzisaten und Herzblut isoliert. Untersuchungen zur Kolonisation des Sputums vor, während und nach der Therapie mit Cephem-Antibiotika der dritten Generation ließen eine Tendenz für das Auftreten dieser Bakterien im Anschluß an die Behandlung erkennen. Unter den grampositiven Kokken warS. faecium am resistentesten gegen diese Antibiotika,S. faecalis, S. epidermidis undS. aureus zeigten eine in der genannten Reihenfolge geringgradigere Resistenz. Die Inzidenz resistenter Isolate war 1984 höher als 1983, was auf eine jährliche Zunahme resistenter Bakterien schließen läßt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature

  1. Saito, A., Hara, K., Yamaguchi, K., Usui, T. Pulmonary infection due to anaerobes in a hospital autopsy survey. Rev. Infect. Dis. 6 (1984) 128–131.

    Google Scholar 

  2. Eron, L. J., Goldenberg, R. I., Park, C. H., Poretz, D. M. Ceftazidime therapy of serious bacterial infections. Antimicrob. Agents Chemother. 23 (1983) 236–241.

    Google Scholar 

  3. Hamilton-Miller, J. M. T., Brumfitt, W., Reynolds, A. V. Cefotaxime (HR 756), a new cephalosporin with exceptional broad-spectrum activityin vitro. J. Antimicrob. Chemother. 4 (1978) 437–444.

    Google Scholar 

  4. Jenkinson, S. G., Briggs, M. S., Bryn, R. D. Cefotaxime in the treatment of pneumococcal pneumonia. J. Antimicrob. Chemother. 6 (1980) 177–180.

    Google Scholar 

  5. Karakusis, P. H., Feczko, J. M., Goodman, L. J., Hanlon, D. M., Harris, A. A., Levin, S., Trenholme, G. M. Clinical efficacy of cefotaxime in serious infections. Antimicrob. Agents Chemother. 21 (1982) 119–124.

    Google Scholar 

  6. Khan, N. J., Bihl, J. A., Schell, R. F., LeFrock, J. L., Weber, S. J. Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins. Antimicrob. Agents Chemother. 26 (1984) 585–590.

    Google Scholar 

  7. Neu, H. C., Chin, N., Labthavikul, P. Comparativein vitro activity and β-lactamase stability of FR 17027, a new orally active cephalosporin. Antimicrob. Agents Chemother. 26 (1984) 174–180.

    Google Scholar 

  8. Pfaller, M. A., Niles, A. C., Murray, P. R. In vitro antibacterial activity of cefpiramide. Antimicrob. Agents Chemother. 25 (1984) 368–372.

    Google Scholar 

  9. Schleupner, C. J., Engle, J. C. Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections. Antimicrob. Agents Chemother. 21 (1982) 327–333.

    Google Scholar 

  10. Chandrasekar, P., Smith, B. R., LeFrock, J. L., Carr, B. Enterococcal superinfection and colonization with azthreonam therapy. Antimicrob. Agents Chemother. 26 (1984) 280–282.

    Google Scholar 

  11. Yu, V. L. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann. Intern. Med. 94 (1981) 784–785.

    Google Scholar 

  12. Cannelly, K. Cefotaxime in routine hospital use. Curr. Med. Res. Opin. 8 (1982) 104–112.

    Google Scholar 

  13. Hanninen, P., Toivanen, A., Vainio, O., Toivanen, P. Cefotaxime in the treatment of lower respiratory tract infections. J. Antimicrob. Chemother. 6 (1980) 181–185.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saito, A., Mori, K., Shigeno, Y. et al. Respiratory superinfections after the use of third-generation cephem antibiotics. Infection 13 (Suppl 1), S89–S95 (1985). https://doi.org/10.1007/BF01644226

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01644226

Keywords

Navigation